| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Hepatobiliary Disorders : Posters : Hepatic Impairment | published Wed, Nov 7, 2007 - 10:31 EST |
| Name | Description | Page Modified |
| Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for Hepatoprotective Effect of Dexamethasone on Transient Transaminitis After Trabectedin (ET-743, Yondelis®) Treatment | Presented at the 2007 ASCO Annual Meeting, Chicago, IL | Fri Nov 02 13:15:24 EDT 2007 |
| Effect of Hepatic Impairment on the Pharmacokinetics of the Novel Glycopeptide Oritavancin | Presented at the 2004 AAPS Annual Meeting, Baltimore, MD | Fri Nov 02 13:15:24 EDT 2007 |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Hepatobiliary Disorders : Posters : Hepatic Impairment | published Wed, Nov 7, 2007 - 10:31 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |